<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://www.medscape.com/cx/rssfeeds/2700.xml</title><link>https://www.medscape.com/cx/rssfeeds/2700.xml</link><description>Individual feed output.</description><lastBuildDate>Mon, 29 Sep 2025 06:36:16 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>Sharp Rise in Cognitive Disability in Adults Younger Than 40</title><link>https://www.medscape.com/viewarticle/sharp-rise-cognitive-disability-adults-younger-than-40-2025a1000pze?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture1.png</image_url><description>Adults report cognitive disabilities at higher rates than a decade ago, with the incidence nearly doubling among those aged less than 40. Medscape Med...</description><pubDate>Mon, 29 Sep 2025 11:20:47 GMT</pubDate></item><item><title>Selpercatinib Linked to Long-Term Survival in Thyroid Cancer</title><link>https://www.medscape.com/viewarticle/selpercatinib-linked-long-term-survival-thyroid-cancer-2025a1000pza?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture9.png</image_url><description>The first-in-class RET kinase inhibitor shows durable responses and favorable progression-free and overall survival rates in the 5-year final analysis...</description><pubDate>Mon, 29 Sep 2025 10:57:59 GMT</pubDate></item><item><title>High Heterogeneity Fails to Affect Post-BLVR Outcomes</title><link>https://www.medscape.com/viewarticle/high-heterogeneity-falls-short-affecting-post-blvr-outcomes-2025a1000pz2?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture9.png</image_url><description>New data suggest that air trapping may be a more useful predictor of post-bronchoscopic lung volume reduction outcomes for patients with emphysema. Me...</description><pubDate>Mon, 29 Sep 2025 10:55:35 GMT</pubDate></item><item><title>Novel SNRI Promising for Major Depression: Phase 2 Data</title><link>https://www.medscape.com/viewarticle/novel-snri-promising-major-depression-phase-2-data-2025a1000pz0?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture8.png</image_url><description>A phase 2 trial suggests that the novel SNRI ammoxetine may effectively treat major depressive disorder while avoiding some side effects common to oth...</description><pubDate>Mon, 29 Sep 2025 10:14:49 GMT</pubDate></item><item><title>Myeloma: Updated Genomic Criteria for High-Risk Cases</title><link>https://www.medscape.com/viewarticle/myeloma-updated-genomic-criteria-high-risk-cases-2025a1000pyu?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png</image_url><description>In the era of triplet and quadruplet therapies, the new criteria reflect the latest advances. Medscape Medical News</description><pubDate>Mon, 29 Sep 2025 10:01:11 GMT</pubDate></item></channel></rss>